|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83 TWD | +0.61% |
|
-0.12% | +1.22% |
TaiMed Biologics Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 563.01 million compared to TWD 413.44 million a year ago. Net loss was TWD 269.29 million compared to TWD 470.93 million a year ago.
Basic loss per share from continuing operations was TWD 1.07 compared to TWD 1.87 a year ago. Diluted loss per share from continuing operations was TWD 1.07 compared to TWD 1.87 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.22% | 644M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
TAIMED BIOLOGICS INC. 
